This is a preview of subscription content, log in via an institution to check access.
Notes
Human Immunodeficiency Virus Prevention Trials Network
Early ART was defined as therapy initiated when CD4+ T-cell count 350−500/µL; delayed ART was initiated when CD4+ T-cell count was < 250/µL.
Reference
Walensky RP, et al. Cost-effectiveness of HIV treatment as prevention in serodiscordant couples. New England Journal of Medicine 369: 1715-25, No. 18, 31 Oct 2013. Available from: URL: http://dx.doi.org/10.1056/NEJMsa1214720
Rights and permissions
About this article
Cite this article
Early ART provides "excellent return on investment". PharmacoEcon Outcomes News 691, 1 (2013). https://doi.org/10.1007/s40274-013-0846-z
Published:
Issue Date:
DOI: https://doi.org/10.1007/s40274-013-0846-z